Haploidentical Hematopoietic Stem Cell Transplant: Clinical Trials

3 trials for Haploidentical Hematopoietic Stem Cell Transplant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 terminated. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 1, Terminated 1
Phase 22Recruiting 2

Follow Haploidentical Hematopoietic Stem Cell Transplant: new trials by email Literature Review of Haploidentical Hematopoietic Stem Cell Transplant trials Research Report on Haploidentical Hematopoietic Stem Cell Transplant

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
Ruxolitinib - Sickle Cell Disease, Hematopoetic Stem Cell Transplant
Phase 1 / Phase 2RecruitingArkansas Children's Hospital Research Institute242026-06-082026-06-04
To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood Cancers
Cyclophosphamide - Haploidentical Hematopoietic Stem Cell Transplant, Hematological Malignancies
Phase 2RecruitingTata Memorial Centre202025-03-262026-07-22
ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant Recipients
ApoGraft - Acute Graft Versus Host Disease, Haploidentical Hematopoietic Stem Cell Transplant
Phase 1TerminatedWashington University School of Medicine42020-12-162023-05-19

Narrower conditions

Anemia, Sickle Cell (1)  ·  Hematologic Neoplasms (1)

Broader conditions

Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Anemia, Hemolytic, Congenital (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Hemoglobinopathies (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)

Interventions

Cyclophosphamide (1)  ·  ruxolitinib (1)

Sponsors

Arkansas Children's Hospital Research Institute (1)  ·  Tata Memorial Centre (1)  ·  Washington University School of Medicine (1)

Countries

United States (2)  ·  India (1)

Top investigators

Laura McLaughlin, MD (1)  ·  Mark Schroeder, M.D. (1)

Results publications

PMID 11719388, PMID 11939602, PMID 11985515, PMID 12171484, PMID 14113077, PMID 1671578, PMID 18489989, PMID 19786984, PMID 2143514, PMID 22863841, PMID 22992668, PMID 25797174, PMID 26284307, PMID 2643045, PMID 31586477, PMID 32973350, PMID 33657221, PMID 34396331, PMID 3897863, PMID 4572127, PMID 4941317, PMID 6131300, PMID 8181080, PMID 8877390, PMID 9867758